Literature DB >> 14507224

Novel multicomponent reaction for the combinatorial synthesis of 2-imidazolines.

Robin S Bon1, Chongen Hong, Marinus J Bouma, Rob F Schmitz, Frans J J de Kanter, Martin Lutz, Anthony L Spek, Romano V A Orru.   

Abstract

[reaction: see text] The three-component condensation between an amine, an aldehyde, and an alpha-acidic isocyanide efficiently provides substituted 2-imidazolines in a one-pot reaction under mild conditions.

Entities:  

Year:  2003        PMID: 14507224     DOI: 10.1021/ol035521g

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  6 in total

Review 1.  Chemistry and biology of multicomponent reactions.

Authors:  Alexander Dömling; Wei Wang; Kan Wang
Journal:  Chem Rev       Date:  2012-03-22       Impact factor: 60.622

2.  Robust generation of lead compounds for protein-protein interactions by computational and MCR chemistry: p53/Hdm2 antagonists.

Authors:  Anna Czarna; Barbara Beck; Stuti Srivastava; Grzegorz M Popowicz; Siglinde Wolf; Yijun Huang; Michal Bista; Tad A Holak; Alexander Dömling
Journal:  Angew Chem Int Ed Engl       Date:  2010-07-19       Impact factor: 15.336

3.  A Van Leusen deprotection-cyclization strategy as a fast entry into two imidazoquinoxaline families.

Authors:  Fabio De Moliner; Christopher Hulme
Journal:  Tetrahedron Lett       Date:  2012-08-24       Impact factor: 2.415

4.  Rapid and efficient hydrophilicity tuning of p53/mdm2 antagonists.

Authors:  Stuti Srivastava; Barbara Beck; Wei Wang; Anna Czarna; Tad A Holak; Alexander Dömling
Journal:  J Comb Chem       Date:  2009 Jul-Aug

Review 5.  Silver and gold-catalyzed multicomponent reactions.

Authors:  Giorgio Abbiati; Elisabetta Rossi
Journal:  Beilstein J Org Chem       Date:  2014-02-26       Impact factor: 2.883

6.  Finding Furfural Hydrogenation Catalysts via Predictive Modelling.

Authors:  Zea Strassberger; Maurice Mooijman; Eelco Ruijter; Albert H Alberts; Ana G Maldonado; Romano V A Orru; Gadi Rothenberg
Journal:  Adv Synth Catal       Date:  2010-09-02       Impact factor: 5.837

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.